Clinical outcome of three fractionation schedules of preoperative radiotherapy for rectal cancer

被引:0
|
作者
Wzietek, Iwona [1 ,2 ]
Wydmanski, Jerzy [1 ,2 ]
Suwinski, Rafal [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiat Oncol, Wybrzeze AK 15, PL-44101 Gliwice, Poland
[2] Inst Oncol, Gliwice Branch, Gliwice, Poland
关键词
preoperative radiotherapy; rectal cancer; fractionation;
D O I
10.1016/S1507-1367(10)60004-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To evaluate the effectiveness and normal tissue reactions of three fractionation schedules of preoperative radiotherapy for locally advanced rectal cancer. MATERIALS AND METHODS: Between 1996 and 2002, 168 patients with locally advanced rectal cancer were treated as follows: 53 patients received 25 Gy in 5 Gy per fraction (group A), 45 received 30 Gy in 3.0 Gy per fraction (group B), and 70 were treated with accelerated hyperfractionation: 42 Gy, 1.5 Gy per fraction, given twice a day with an inter-fraction interval of 6 hours (group C). The clinical characteristics of the groups were comparable. The patients did not receive concurrent chemotherapy. A Cox proportional hazard regression model was used to analyze the factors which may influence loco-regional tumour control (LRC) and overall survival (OS). RESULTS: The following variables significantly influenced LRC: fractionation scheme (5-year LRC 80%, 69%, and 90% in groups A, B, C respectively, p=0.016), haemoglobin concentration before radiotherapy (p=0.012) and postoperative chemotherapy (p=0.01). Age, sex, stage of disease, location of tumour (distance of the tumour from the anal verge) and performance status did not appear significant for LRC. The overall 5-year OS was 64%, 59% and 74% in groups A, B, C respectively (p=0.056). The OS was significantly influenced by postoperative pathological stage (p=0.006), tumour location (p=0.015) and postoperative chemotherapy (p=0.047). The most frequent acute radiation reaction was mild/severe diarrhoea, which appeared in 5%, 21.6% and 65.5% of the patients from groups A-C respectively. The median wound healing time in those who underwent abdomino-perineal resections was 6, 6 and 4 weeks. Other reactions appeared less relevant. There was no significant difference in the incidence of late effects among the three treatment groups. CONCLUSION: While due to the non-randomized character of the study the conclusions should be regarded as hypothesis-generating only, the analysis has shown an acceptable local effectiveness and tolerance of schedules A and C, and disappointing effectiveness of schedule B. The present study thus supports the data which suggest that the clinical effect of preoperative radiotherapy for rectal cancer is influenced not only by total radiation dose but also by overall radiation treatment time and dose per fraction.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [21] Outcome of rectal cancer surgery after the introduction of preoperative radiotherapy in a low-volume hospital
    Doeksen A.
    Tanis P.J.
    Vrouenraets B.C.
    Gooszen J.A.H.
    Van Lanschot J.J.B.
    Van Tets W.F.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 63 - 70
  • [22] Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer
    Meng, Wen-Jian
    Pathak, Surajit
    Ding, Zhen-Yu
    Zhang, Hong
    Adell, Gunnar
    Holmlund, Birgitta
    Li, Yuan
    Zhou, Zong-Guang
    Sun, Xiao-Feng
    CANCER BIOLOGY & THERAPY, 2015, 16 (12) : 1738 - 1745
  • [23] Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer
    Chao, M
    Gibbs, P
    Tjandra, J
    Cullinan, M
    McLaughlin, S
    Faragher, I
    Skinner, I
    Jones, I
    ANZ JOURNAL OF SURGERY, 2005, 75 (05) : 286 - 291
  • [24] uPA and PAI-1 in Rectal Cancer - Relationship to Radiotherapy and Clinical Outcome
    Angenete, Eva
    Langenskiold, Marcus
    Palmgren, Ingrid
    Falk, Peter
    Oresland, Tom
    Ivarsson, Marie-Louise
    JOURNAL OF SURGICAL RESEARCH, 2009, 153 (01) : 46 - 53
  • [25] The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
    Shibamoto, Yuta
    Iwata, Hiromitsu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
  • [26] The usefulness of immunohistochemical evaluation of dihydropyrimidine dehydrogenase for rectal cancer treated with preoperative radiotherapy
    Komuro, Y
    Watanabe, T
    Tsuno, N
    Kitayama, J
    Inagaki, N
    Nishida, M
    Nagawa, H
    HEPATO-GASTROENTEROLOGY, 2003, 50 (52) : 906 - 911
  • [27] The prognostic value of S-phase fraction in preoperative radiotherapy of rectal cancer
    Lammering, G
    Taher, MM
    Borchard, F
    Gruenagel, HH
    Porschen, R
    ONCOLOGY REPORTS, 2001, 8 (01) : 201 - 206
  • [28] Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer
    Myerson, RJ
    Singh, A
    Birnbaum, EH
    Fry, RD
    Fleshman, JW
    Kodner, IJ
    Lockett, MA
    Picus, J
    Walz, BJ
    Read, TE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03): : 665 - 674
  • [29] The effect of belly board location in rectal cancer patients treated with preoperative radiotherapy
    Lee, Seok Ho
    Kim, Tae Hyun
    Kim, Dae Yong
    Cho, Kwan Ho
    Kim, Joo-Young
    Park, Sung Yong
    Kim, Dae Hyun
    Lim, Seok-Byung
    Choi, Hyo Seong
    Chang, Hee Jin
    CLINICAL ONCOLOGY, 2006, 18 (06) : 441 - 446
  • [30] Radiotherapy of rectal cancer
    Wolf, M.
    Zehentmayr, F.
    Belka, C.
    RADIOLOGE, 2012, 52 (06): : 545 - 549